Hexagon Nutrition IPO listing on June 12, 2026: GMP check

Listing confirmed for June 12 on BSE and NSE

Hexagon Nutrition’s shares are scheduled to list on Friday, June 12, 2026, after the company’s initial public offering (IPO) drew strong investor demand during the subscription window. The stock is set to debut on both the BSE and the NSE, as per the listing schedule cited in market updates.

A BSE notice also stated that, effective June 12, 2026, the equity shares of Hexagon Nutrition Limited will be listed and admitted to dealings under the ‘T’ Group of Securities. For investors, the listing completes the IPO timeline that began with subscriptions opening on June 5 and closing on June 9.

IPO timeline: key dates investors tracked

The public issue opened for subscription on June 5, 2026, and closed on June 9, 2026. The basis of allotment is being finalised on June 10, 2026, with shares expected to be credited to demat accounts on June 11, ahead of listing on June 12.

This sequence is typical for mainboard IPOs, and it has kept attention on two near-term checkpoints: allotment confirmation and the listing day performance. In this case, grey market cues have been mixed, with reported premiums varying across different points in the IPO process.

Issue size, structure, and what was on offer

The IPO size was reported at about ₹138.87 crore (also cited as ₹139 crore in some updates). The issue is structured entirely as an Offer for Sale (OFS) of 3.09 crore shares, meaning existing shareholders are selling their shares and the company is not raising fresh capital through this issue.

The price band was fixed at ₹42 to ₹45 per share, and the final issue price referenced in updates is ₹45 per share. The lot size for retail applicants was 333 shares, implying a minimum application amount of ₹14,985 at the upper end of the price band.

Subscription demand: strong response during bidding

The issue received a strong response from investors during the bidding period. One report cited that, against 2.16 crore shares, the IPO was subscribed 4.60 times overall, with retail investors subscribing their portion 6.22 times.

These figures suggest healthy participation, especially from retail applicants. However, subscription strength does not guarantee listing gains, so attention has remained on listing-day demand and broader market conditions.

Grey market premium (GMP): why signals turned muted

Grey market premium (GMP) is an unofficial indicator, and market experts have cautioned it should not be treated as a reliable predictor of actual listing-day performance. Still, it is widely tracked because it reflects perceived demand in the unlisted market.

In Hexagon Nutrition’s case, the GMP has been reported at different levels across the IPO period:

• Around ₹12 per share on the opening day in one update, implying an estimated listing price near ₹57 (about 27% over ₹45).
• Around ₹7 per share by Day 2 in another update, implying an estimated listing near ₹52 (about 15.56% over ₹45).
• Around ₹3.5 per share ahead of allotment in one report, implying nearly 7.8% over ₹45.
• A range of ₹3.5 to ₹6.5 per share around June 9-10, implying a potential listing range of ₹48.5 to ₹51.5 (about 8% to 14% over ₹45).
• ₹2.75 per share closer to listing in one update, implying an estimated listing price of ₹47.75 (a premium of 6.11% over ₹45).

This sequence points to cooling grey market sentiment as the IPO moved from launch to allotment and listing.

Estimated listing price: what the reported numbers imply

Based on the reported GMP of ₹2.75, the estimated listing price cited is ₹47.75 per share, implying a 6.11% premium over the issue price of ₹45. Analysts quoted in updates also expected a minor premium on debut.

Separately, the GMP range of ₹3.5 to ₹6.5 suggested a broader expected listing zone of ₹48.5 to ₹51.5 per share, implying an 8% to 14% listing gain on the same issue price. Because these are unofficial cues and can shift quickly, investors typically compare them against actual order flow on listing day.

Exchange details: BSE ‘T’ Group classification

The BSE notice indicated the stock would be listed in the ‘T’ Group of Securities. Investors often watch such classifications because they can influence the way the stock trades, particularly in early sessions.

With the listing on both exchanges, investors will be able to track price discovery and volumes across BSE and NSE on June 12.

Key facts snapshot

Market impact: what matters for investors on listing day

For IPO investors, the immediate market impact is concentrated in two areas: listing price relative to the issue price, and the stock’s liquidity and volatility in early trades. The reported GMP cooling from double-digit levels to low single digits suggests that expectations moderated as listing approached.

The other key factor is that the IPO is entirely an OFS. Since the issue does not include fresh capital, investors may focus more on near-term demand-supply dynamics at listing, and less on how new funds might be used.

Why this listing is being watched

Hexagon Nutrition’s IPO attracted broad attention due to its strong subscription figures and the active grey market tracking throughout the issue period. The wide range of GMP readings reported across different days highlights how quickly sentiment can change.

The clearest confirmed milestone now is the listing itself on June 12, 2026, on both BSE and NSE. The actual listing price and subsequent trading will settle the debate created by mixed grey market indications.

Conclusion

Hexagon Nutrition’s IPO is set to list on June 12, 2026, with the issue priced at ₹45 per share and the offer size reported at about ₹138.87 crore. Grey market signals have been muted closer to listing, with one update indicating a ₹2.75 GMP and an estimated listing price of ₹47.75. Investors will next watch the opening trade and early volumes on BSE and NSE on Friday to see how the stock prices against these expectations.